Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery

NCT07539623 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT07539623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07539623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Phase 3
Overall status
Recruiting
Start date
May 1, 2026
Completion date
December 22, 2026
Enrollment
235 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bariatric surgery, cardiac surgery with sternotomy, post-operative pain